P95 developed the Vaccine Effectiveness Misclassification (VEMC) application to perform calculations to quantify and adjust for the effect of exposure misclassification using novel statistical methods developed in the IMI ADVANCE project.
More information:
https://journals.plos.org/plosone/article/related?id=10.1371/journal.pone.0199180
P95 developed this online calculation tool during the IMI ADVANCE project to allow researchers to calculate and adjust various interrelated indices (sensitivity, specificity, etc.) connected to epidemiologic research.
P95 developed the Electronic Study Support Application as a one-stop data upload and data quality assessment application for database custodians to use with their seasonal influenza data.
P95 has also been contracted to develop various web applications for top pharma clients and international partners (such as WHO, CEPI, etc.) on vaccine coverage, systematic literature review data and other topics.
Alexandridou, M., T. Cattaert and T. Verstraeten (2021). “Estimation of Risk of Death Attributable to Acute Gastroenteritis Not Caused by Clostridioides difficile Infection Among Hospitalized Adults in England.” Clin Epidemiol 13: 309-315. 10.2147/CLEP.S296516
Baay, M., B. Lina, A. Fontanet, A. Marchant, M. Saville, P. Sabot, J. Vandeputte and P. Neels (2021). “Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic.” Biologicals 69: 76-82. 10.1016/j.biologicals.2020.11.003
Baay, M. and P. Neels (2021). “Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development.” Front Immunol 12: 658783. 10.3389/fimmu.2021.658783
Biccler, J., K. Bollaerts, P. Vora, E. Sole, L. A. G. Rodriguez, A. Lanas, R. E. Langley and M. S. Gabarró (2021). “Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model.” Int J Cardiol Heart Vasc 36: 100851. 10.1016/j.ijcha.2021.100851
© Copyright 2022 | P95 | ALL RIGHTS RESERVED